RNA-Targeted Drug Approved for Preventing Hereditary Angioedema Attacks

By News Health
3 hours Ago

(MedPage Today) — Donidalorsen (Dawnzera) received FDA approval for prophylactic treatment of hereditary angioedema (HAE) in adults and kids 12 years and older, Ionis Pharmaceuticals announced on Thursday.
The RNA-targeted therapy, a first for…

Source link : https://www.medpagetoday.com/allergyimmunology/allergy/117112

Author :

Publish date : 2025-08-21 21:19:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Fall COVID Vax Mayhem; Rib Removal Surgery; DO Chimes In on 'Biggest Loser' Drama

Whistleblower Nurses Say Patient Safety Hasn't Improved Since Investigation

Weight-Loss Intervention in Breast Cancer Patients Proves Fruitful

Parkinson's Risk Rises With Metabolic Syndrome

DOJ Demanded Details on Transgender Patients From at Least One Hospital

We could get most metals for clean energy without opening new mines